Targeting COVID-19 Vaccine Hesitancy in Minority Populations in the US: Implications for Herd Immunity

There has been a continuous underrepresentation of minorities in healthcare research and vaccine trials, along with long-standing systemic racism and discrimination that have been fueling the distrust of the healthcare system among these communities for decades. The history and legacy of racial inju...

Full description

Bibliographic Details
Main Authors: James E. K. Hildreth, Donald J. Alcendor
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/9/5/489
_version_ 1797534617580863488
author James E. K. Hildreth
Donald J. Alcendor
author_facet James E. K. Hildreth
Donald J. Alcendor
author_sort James E. K. Hildreth
collection DOAJ
description There has been a continuous underrepresentation of minorities in healthcare research and vaccine trials, along with long-standing systemic racism and discrimination that have been fueling the distrust of the healthcare system among these communities for decades. The history and legacy of racial injustices and negative experiences within a culturally insensitive healthcare system have greatly contributed to vaccine hesitancy among ethnic minorities. COVID-19 vaccine hesitancy will impact vaccine uptake in the US, subsequently hindering the establishment of herd immunity (75–85% of the population vaccinated) to mitigate SARS-CoV-2 infection and transmission. Information targeting underserved racial/ethnic minorities in the US in a culturally competent manner has been lacking. This information is crucial for educating these communities about COVID-19 vaccines and their distribution as well as dispelling misinformation regarding vaccine trials, safety, and efficacy. This lack of education has greatly contributed to COVID-19 vaccine hesitancy and will increase disparities in vaccine uptake. Moreover, timely vaccinations are also essential to curtailing virus transmission and the emergence of SARS-CoV-2 variants that may evade the immune response produced by the three existing COVID-19 vaccines.
first_indexed 2024-03-10T11:33:04Z
format Article
id doaj.art-bf77a695a0c84eb2bc860fe0b0e2e0db
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-03-10T11:33:04Z
publishDate 2021-05-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-bf77a695a0c84eb2bc860fe0b0e2e0db2023-11-21T19:08:20ZengMDPI AGVaccines2076-393X2021-05-019548910.3390/vaccines9050489Targeting COVID-19 Vaccine Hesitancy in Minority Populations in the US: Implications for Herd ImmunityJames E. K. Hildreth0Donald J. Alcendor1Center for AIDS Health Disparities Research, Department of Microbiology and Immunology, School of Medicine, Meharry Medical College, 1005 Dr. D.B. Todd Jr. Blvd., Nashville, TN 37208-3599, USACenter for AIDS Health Disparities Research, Department of Microbiology and Immunology, School of Medicine, Meharry Medical College, 1005 Dr. D.B. Todd Jr. Blvd., Nashville, TN 37208-3599, USAThere has been a continuous underrepresentation of minorities in healthcare research and vaccine trials, along with long-standing systemic racism and discrimination that have been fueling the distrust of the healthcare system among these communities for decades. The history and legacy of racial injustices and negative experiences within a culturally insensitive healthcare system have greatly contributed to vaccine hesitancy among ethnic minorities. COVID-19 vaccine hesitancy will impact vaccine uptake in the US, subsequently hindering the establishment of herd immunity (75–85% of the population vaccinated) to mitigate SARS-CoV-2 infection and transmission. Information targeting underserved racial/ethnic minorities in the US in a culturally competent manner has been lacking. This information is crucial for educating these communities about COVID-19 vaccines and their distribution as well as dispelling misinformation regarding vaccine trials, safety, and efficacy. This lack of education has greatly contributed to COVID-19 vaccine hesitancy and will increase disparities in vaccine uptake. Moreover, timely vaccinations are also essential to curtailing virus transmission and the emergence of SARS-CoV-2 variants that may evade the immune response produced by the three existing COVID-19 vaccines.https://www.mdpi.com/2076-393X/9/5/489health disparitiescoronavirusvaccine hesitancySARS-CoV-2COVID-19minorities populations
spellingShingle James E. K. Hildreth
Donald J. Alcendor
Targeting COVID-19 Vaccine Hesitancy in Minority Populations in the US: Implications for Herd Immunity
Vaccines
health disparities
coronavirus
vaccine hesitancy
SARS-CoV-2
COVID-19
minorities populations
title Targeting COVID-19 Vaccine Hesitancy in Minority Populations in the US: Implications for Herd Immunity
title_full Targeting COVID-19 Vaccine Hesitancy in Minority Populations in the US: Implications for Herd Immunity
title_fullStr Targeting COVID-19 Vaccine Hesitancy in Minority Populations in the US: Implications for Herd Immunity
title_full_unstemmed Targeting COVID-19 Vaccine Hesitancy in Minority Populations in the US: Implications for Herd Immunity
title_short Targeting COVID-19 Vaccine Hesitancy in Minority Populations in the US: Implications for Herd Immunity
title_sort targeting covid 19 vaccine hesitancy in minority populations in the us implications for herd immunity
topic health disparities
coronavirus
vaccine hesitancy
SARS-CoV-2
COVID-19
minorities populations
url https://www.mdpi.com/2076-393X/9/5/489
work_keys_str_mv AT jamesekhildreth targetingcovid19vaccinehesitancyinminoritypopulationsintheusimplicationsforherdimmunity
AT donaldjalcendor targetingcovid19vaccinehesitancyinminoritypopulationsintheusimplicationsforherdimmunity